The main visible indicators of Jatcorp revenue progress, such as the sales promotions we have seen in China and Australia on Jatcorp head company products would not have flowed through in the upcoming March 4c release.
ANMA upgrades are probably still in progress possibly slowing normal factory output let alone the new double capacity. The Poupin and Vmeat products are in the early stages and there is probably still some logistics issues that may have effected the March 4c.
I also think it is best not to be too optimistic on the release of the March 4C cash flow figures as most of the cash from activity we have seen will not show until this current June 4C and the next.
A bit of a cash flow inbound increase from the December 4C as a direction indicator would be good though. I would also like to see a similar update on progress on the various agreements like we saw in the March 4c.
Better investor information and relations appears to be becoming the norm for Jatcorp unlike historical critical gaps in this.
GLTAH DYOR
- Forums
- ASX - By Stock
- JAT
- Jat 2.0 - 2021 - A New Year
Jat 2.0 - 2021 - A New Year, page-572
-
-
- There are more pages in this discussion • 371 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add JAT (ASX) to my watchlist
|
|||||
Last
78.0¢ |
Change
0.020(2.63%) |
Mkt cap ! $64.94M |
Open | High | Low | Value | Volume |
76.0¢ | 78.0¢ | 73.5¢ | $170.0K | 222.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12042 | 75.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
78.0¢ | 44718 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 12042 | 0.750 |
2 | 18149 | 0.735 |
1 | 30000 | 0.730 |
1 | 20000 | 0.720 |
1 | 19895 | 0.670 |
Price($) | Vol. | No. |
---|---|---|
0.780 | 44718 | 3 |
0.785 | 26667 | 2 |
0.790 | 132950 | 4 |
0.800 | 42467 | 4 |
0.820 | 6903 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
JAT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online